Healthcare provider profile · identity verified

Alex N Hardy, D.O.

Family Practice · VALENCIA, CA · NPI 1902246580

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	703	207
Amlodipine Besylate	Amlodipine Besylate	347	95
Levothyroxine Sodium	Levothyroxine Sodium	246	58
Rosuvastatin Calcium	Rosuvastatin Calcium	228	76
Lisinopril	Lisinopril	203	57
Omeprazole	Omeprazole	202	70
Losartan Potassium	Losartan Potassium	195	64
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	178	39
Gabapentin	Gabapentin	175	55
Irbesartan	Irbesartan	162	46
Hydrochlorothiazide	Hydrochlorothiazide	150	46
Metformin Hcl	Metformin Hcl	143	42
Furosemide	Furosemide	140	38
Metoprolol Succinate	Metoprolol Succinate	132	37
Ozempic	Semaglutide	131	23
Alprazolam	Alprazolam	127	24
Tamsulosin Hcl	Tamsulosin Hcl	114	33
Famotidine	Famotidine	108	34
Eliquis	Apixaban	96	26
Albuterol Sulfate Hfa	Albuterol Sulfate	92	29
Sertraline Hcl	Sertraline Hcl	85	26
Pregabalin	Pregabalin	82	17
Lorazepam	Lorazepam	81	18
Fluticasone Propionate	Fluticasone Propionate	79	45
Metoprolol Tartrate	Metoprolol Tartrate	79	24
Ibuprofen	Ibuprofen	77	31
Quetiapine Fumarate	Quetiapine Fumarate	76	16
Potassium Chloride	Potassium Chloride	72	15
Escitalopram Oxalate	Escitalopram Oxalate	70	20
Trazodone Hcl	Trazodone Hcl	69	29
Zolpidem Tartrate	Zolpidem Tartrate	65	14
Meloxicam	Meloxicam	64	17
Montelukast Sodium	Montelukast Sodium	64	16
Carvedilol	Carvedilol	61	18
Pravastatin Sodium	Pravastatin Sodium	60	14
Atenolol	Atenolol	58	19
Pantoprazole Sodium	Pantoprazole Sodium	56	22
Tramadol Hcl	Tramadol Hcl	55	16
Triamcinolone Acetonide	Triamcinolone Acetonide	55	29
Allopurinol	Allopurinol	51	14
Benazepril Hcl	Benazepril Hcl	50	15
Ondansetron Odt	Ondansetron	45	17
Donepezil Hcl	Donepezil Hcl	43	suppressed
Metformin Hcl Er	Metformin Hcl	43	12
Alendronate Sodium	Alendronate Sodium	41	14
Duloxetine Hcl	Duloxetine Hcl	41	13
Buspirone Hcl	Buspirone Hcl	40	11
Diclofenac Sodium	Diclofenac Sodium	38	15
Clonazepam	Clonazepam	37	suppressed
Azithromycin	Azithromycin	36	34
Prednisone	Prednisone	35	23
Hydralazine Hcl	Hydralazine Hcl	34	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	12
Mounjaro	Tirzepatide	34	suppressed
Enalapril Maleate	Enalapril Maleate	33	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	33	24
Celecoxib	Celecoxib	32	13
Clopidogrel	Clopidogrel Bisulfate	32	12
Olmesartan Medoxomil	Olmesartan Medoxomil	32	suppressed
Bupropion Xl	Bupropion Hcl	31	suppressed
Diazepam	Diazepam	31	suppressed
Digoxin	Digoxin	31	suppressed
Jardiance	Empagliflozin	31	12
Naproxen	Naproxen	31	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	30	suppressed
Finasteride	Finasteride	27	suppressed
Methocarbamol	Methocarbamol	27	suppressed
Spironolactone	Spironolactone	27	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Trulicity	Dulaglutide	25	suppressed
Simvastatin	Simvastatin	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Glipizide	Glipizide	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Entresto	Sacubitril/Valsartan	20	suppressed
Metronidazole	Metronidazole	20	suppressed
Spiriva Respimat	Tiotropium Bromide	20	suppressed
Glipizide Er	Glipizide	19	suppressed
Hydrocortisone	Hydrocortisone	19	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	19	suppressed
Cephalexin	Cephalexin	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Lidocaine	Lidocaine	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Amoxicillin	Amoxicillin	16	13
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	14
Diltiazem 12hr Er	Diltiazem Hcl	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Terbinafine Hcl	Terbinafine Hcl	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Clotrimazole	Clotrimazole	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Fluconazole	Fluconazole	13	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Valsartan	Valsartan	13	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Levofloxacin	Levofloxacin	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Pentasa	Mesalamine	12	suppressed
Ramelteon	Ramelteon	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Ciclopirox	Ciclopirox	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Estradiol	Estradiol	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Telmisartan	Telmisartan	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error